Evidence map›Paper›PMID 24007594›Full record

ArticleACS chemical neuroscience2013

In silico cross seeding of Aβ and amylin fibril-like oligomers.

Workalemahu M Berhanu, Fatih Yaşar, Ulrich H E Hansmann

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Stability of Aβ-fibril fragments in the presence of fatty acids.Protein science : a publication of the Protein Society · 2019
    Article
  15. Modifiable Risk Factors for Alzheimer's Disease.Frontiers in aging neuroscience · 2019
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Amylin alters human brain pericyte viability and NG2 expression.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Workalemahu M BerhanuDepartment of Chemistry & Biochemistry, University of Oklahoma , Norman, Oklahoma 73019, United States.
Fatih Yaşar
Ulrich H E Hansmann
University of Oklahoma · US

Funding

Folding, Mis-Folding and Aggregation of Small ProteinsR01GM062838 · NIGMS · UNIVERSITY OF OKLAHOMA · PI HANSMANN, ULRICH H.E. · 2003 to 2012
$1.4M
NIGMS NIH HHS GM62838
6 · The paper itself

Abstract

Recent epidemiological data have shown that patients suffering from Type 2 Diabetes Mellitus have an increased risk to develop Alzheimer's disease and vice versa. A possible explanation is the cross-sequence interaction between Aβ and amylin. Because the resulting amyloid oligomers are difficult to probe in experiments, we investigate stability and conformational changes of Aβ-amylin heteroassemblies through molecular dynamics simulations. We find that Aβ is a good template for the growth of amylin and vice versa. We see water molecules permeate the β-strand-turn-β-strand motif pore of the oligomers, supporting a commonly accepted mechanism for toxicity of β-rich amyloid oligomers. Aiming for a better understanding of the physical mechanisms of cross-seeding and cell toxicity of amylin and Aβ aggregates, our simulations also allow us to identify targets for the rational design of inhibitors against toxic fibril-like oligomers of Aβ and amylin oligomers.

Indexed as

Amino Acid MotifsAmyloid beta-PeptidesCell Membrane PermeabilityDiabetes Mellitus, Type 2HumansHydrophobic and Hydrophilic InteractionsIslet Amyloid PolypeptideModels, ChemicalMolecular Dynamics SimulationNeurofibrillary TanglesProtein StabilityProtein Structure, Tertiarytau ProteinsAmyloid beta-PeptidesIslet Amyloid Polypeptidetau Proteins

Identifiers

PMID24007594
PMCPMC3837374
OpenAlexW2079000544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.